Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-002313
Filing Date
2018-01-30
Accepted
2018-01-30 18:37:14
Documents
1
Period of Report
2018-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7327
  Complete submission text file 0000899243-18-002313.txt   8902
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
PureTech Health LLC (Reporting) CIK: 0001727395 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 18560481